Plasma miR-126 as a potential marker predicting major adverse cardiac events in patients after percu

• 作 者: Xi-Yong Yu Ji-Yan Chen Hong Wu Zhi-Wei Zheng Zhi-Hong Chen Xin-Xin Li Ya-Ling Han Shi-Long Zhong
• 机 构: MedicalResearchCenterofGuangdongGeneralHospital;DepartmentofCardiology,GuangdongCardiovascularInstit
• 出 处: 第二届全国治疗药物监测学术年会
• 发表日期: 2012年8期

　　Background:Circulating miRNAs have been considered as promising novel biomarkers for prognosis of cardiovascular diseases.The present study was aimed to evaluate the contribution ofplasma miRNAs regulating the biology of endothelium and smooth muscle cells or targeting PON1 and P2RY12 to the occurrence of major adverse cardiovascular events (MACE) and bleeding events in patients after percutaneous coronary intervention (PCI).